Skip to content

AlphaCognition Inc.

AlphaCognition, Inc. is a privately held biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. They embarked on research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS), also called Lou Gehrig’s Disease. To date, both are very serious conditions that have major unmet medical needs. Formerly known as Neurodyn Inc.


Scroll To Top